Matinas BioPharma Hldgs Q2 EPS $(0.02) Beats $(0.03) Estimate

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 33.33 percent increase over losses of $(0.03) per share

byBenzinga Newsdesk

August 10, 2021

1 minute read

Credit Suisse Downgrades DT Midstream to Neutral, Raises Price Target to $58

By Benzinga Newsdesk

Today, 3:53 PM

Credit Suisse analyst Spiro Dounis downgrades DT Midstream (NYSE:DTM) from Outperform to Neutral and raises the price target from $55 to $58.

DTM

Hong Kong Stocks Open Mixed Ahead Of US Jobs Data: Is The Market Ignoring Chengdu Lockdown?

By Bhavik Nair

Today, 3:53 PM

Hong Kong stocks opened mixed on Friday ahead of the release of the U.S. jobs report that would give more cues on the course and aggression of the U.S. rate hike later this month. The Hang Seng index lost 0.5% in opening trade. Shares of XPeng lose over 3% in the morning session.

BABA

Luminar Technologies Shares Spike Higher; Arm, PACCAR Executives Join Co

By Benzinga Newsdesk

Today, 3:53 PM

Luminar Technologies, Inc. (NASDAQ:LAZR), the global leader in automotive lidar hardware and software technology, today announced the addition of two new executives to help enable its next phase of growth and execution.

LAZR